Cited by 40Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.

Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials

Open access

Abstract

Objective To investigate whether the Revised Self-Monitoring Scale (RSMS), an informant measure of socioemotional sensitivity, is a potential clinical endpoint for treatment trials for patients with behavioral variant frontotemporal dementia (bvFTD). Methods We investigated whether RSMS informant ratings reflected disease severity in 475 participants (71 bvFTD mutation+, 154 bvFTD mutation−, 12 behavioral mild cognitive impairment [MCI] mutation+, 98 asymptomatic mutation+, 140 asymptomatic mutation−). In a subset of 62 patients (20 bvFTD mutation+, 35 bvFTD mutation−, 7 MCI mutation+) who had at least 2 time points of T1-weighted images available on the same 3T scanner, we examined longitudinal changes in RSMS score over time and its correspondence to progressive gray matter atrophy. Results RSMS score showed a similar pattern in mutation carriers and noncarriers, with significant drops at each stage of progression from asymptomatic to very mild, mild, moderate, and severe disease (F4,48 = 140.10, p < 0.001) and a significant slope of decline over time in patients with bvFTD (p = 0.004, 95% confidence interval [CI] −1.90 to −0.23). More rapid declines on the RSMS corresponded to faster gray matter atrophy predominantly in the salience network (SN), and RSMS score progression best predicted thalamic volume in very mild and mild disease stages of bvFTD. Higher RSMS score predicted more caregiver burden (p < 0.001, 95% CI −0.30 to −0.11). Conclusions The RSMS is sensitive to progression of both socioemotional symptoms and SN atrophy in patients with bvFTD and corresponds directly to caregiver burden. The RSMS may be useful in both neurologic practice and clinical trials aiming to treat behavioral symptoms of patients with bvFTD.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000009451

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. 10.1212/WNL.78.1_supplement.IN9-2.003 · DOI

Cited by

Sorted by citations

Metadata

Authors
Toller, G., Ranasinghe, K., Cobigo, Y., Staffaroni, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto-Reilly, K., Fields, J., Fong, J., Forsberg, L., Ghoshal, N., Graff-Radford, N., Grossman, M., Heuer, H., Hsiung, G.-Y., Huey, E., Irwin, D., Kantarci, K., Kaufer, D., Kerwin, D., Knopman, D., Kornak, J., Kramer, J., Litvan, I., Mackenzie, I., Mendez, M., Miller, B., Rademakers, R., Ramos, E., Rascovsky, K., Roberson, E., Syrjanen, J., Tartaglia, C., Weintraub, S., Boeve, B., Boxer, A., Rosen, H., Rankin, K., & the ARTFL/LEFFTDS Consortium
Affiliations
  • Northwestern University (US)
  • Mayo Clinic (US)
  • From the Department of Neurology (G.T., K.R., Y.C., A.S., J. Fong, H.H., J.K., J.K., B.M., A.B., H.R., K.R.), Memory and Aging Center, University of California, San Francisco; Case Western Reserve University (B.A.), Cleveland, OH; Mayo Clinic (D.B., J. Fields, L.F., N.G.-R., K.K., D. Knopman, J.S., B.B.), Rochester, MN; University of California (G.C., M.M., E.R.), Los Angeles; Department of Neurology (B.D.), Massachusetts General Hospital, Harvard Medical School, Boston; University of Washington (K...
Venue
Neurology
Published
2020-06-02
Volume
94
Issue
22
Pages
e2384-e2395
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3023139446
Cited by
40
References
52
Citations by year
2026: 3 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 2
FWCI
4.01
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177667)
  • National Institute on Aging (K23AG021606, R01AG029577, K23AG061253, P01AG066597, P01AG017586, RF1AG029577, K08AG058749, U01AG045390, P50AG005136, K24AG045333, R01AG038791, U19AG063911, P01AG019724, P30AG066462, P30AG062422, R01AG054519, P30AG066509, R01AG032289, P50AG023501)
  • National Institute of Neurological Disorders and Stroke (U54NS092089)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
behavioral variant frontotemporal dementia, informant ratings, disease progression, gray matter atrophy, salience network, thalamic volume, mutation carriers, caregiver burden, clinical trial endpoints, treatment trials
MeSH terms
Self-Management, Adult, Aged, Clinical Trials as Topic, Facial Expression, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Surveys and Questionnaires, Reproducibility of Results, Caregivers, Expressed Emotion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review